Charles Robb

2017

In 2017, Charles Robb earned a total compensation of $1.8M as Chief Financial Officer and Secretary at Corcept Therapeutics.

Compensation breakdown

Bonus$320,000
Option Awards$1,062,589
Salary$397,929
Total$1,780,518

Robb received $1.1M in option awards, accounting for 60% of the total pay in 2017.

Robb also received $320K in bonus and $397.9K in salary.

Rankings

In 2017, Charles Robb's compensation ranked 6,083rd out of 14,666 executives tracked by ExecPay. In other words, Robb earned more than 58.5% of executives.

ClassificationRankingPercentile
All
6,083
out of 14,666
59th
Division
Manufacturing
2,235
out of 5,768
61st
Major group
Chemicals And Allied Products
705
out of 2,074
66th
Industry group
Drugs
543
out of 1,730
69th
Industry
Pharmaceutical Preparations
427
out of 1,329
68th
Source: SEC filing on April 27, 2020.

Robb's colleagues

We found four more compensation records of executives who worked with Charles Robb at Corcept Therapeutics in 2017.

2017

Joseph Belanoff

Corcept Therapeutics

Chief Executive Officer

2017

Sean Maduck

Corcept Therapeutics

Senior Vice President, Commercial

2017

G Robb

Corcept Therapeutics

Chief Financial Officer

2017

Robert Fishman

Corcept Therapeutics

Chief Medical Officer

News

In-depth

You may also like